OTC Pharmaceuticals BRIC (Brazil, Russia, India, China) Industry Guide_2016

Date: October 21, 2016
Pages: 104
Price:
US$ 995.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: O9BB0E5A212EN
Leaflet:

Download PDF Leaflet

OTC Pharmaceuticals BRIC (Brazil, Russia, India, China) Industry Guide_2016
SUMMARY

The BRIC OTC Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY FINDINGS
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the BRIC otc pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the BRIC otc pharmaceuticals market
  • Leading company profiles reveal details of key otc pharmaceuticals market players' BRIC operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the BRIC otc pharmaceuticals market with five year forecasts by both value and volume
  • Compares data from Brazil, Russia, India, and China, alongside individual chapters on each country
SYNOPSIS

Essential resource for top-line data and analysis covering the BRIC otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends and leading companies.

REASONS TO BUY
  • What was the size of the BRIC otc pharmaceuticals market by value in 2015?
  • What will be the size of the BRIC otc pharmaceuticals market in 2020?
  • What factors are affecting the strength of competition in the BRIC otc pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the BRIC otc pharmaceuticals market?
KEY HIGHLIGHTS
  • Brazil, Russian Federation, India and China (BRIC) are the emerging and fast growing countries within the otc pharmaceuticals industry and had a total market value of $29,244.5 million in 2015. India was the fastest growing country with a CAGR of 9.7% over the 2011-15 period.
  • Within the otc pharmaceuticals industry, China is the leading country among the BRIC nations with market revenues of $19,005.3 million in 2015. This was followed by Brazil, Russia and India with a value of $4,381.0, $3,795.5, and $2,062.7 million, respectively.
  • China is expected to lead the otc pharmaceuticals industry in the BRIC nations with a value of $25,516.5 million in 2020, followed by Brazil, Russia, India with expected values of $6,200.1, $4,597.8 and $3,252.5 million, respectively.
Introduction
What is this report about?
Who is the target reader?
How to use this report
Definitions
BRIC OTC Pharmaceuticals
Industry Outlook
OTC Pharmaceuticals in Brazil
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in China
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in India
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Russia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Company Profiles
Leading companies
Appendix
Methodology
About MarketLine

LIST OF TABLES

Table 1: BRIC otc pharmaceuticals industry, revenue($m), 2011-20
Table 2: BRIC otc pharmaceuticals industry, revenue($m), 2011-15
Table 3: BRIC otc pharmaceuticals industry, revenue($m), 2015-20
Table 4: Brazil OTC pharmaceuticals market value: $ million, 2011-15
Table 5: Brazil OTC pharmaceuticals market category segmentation: $ million, 2015
Table 6: Brazil OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 7: Brazil OTC pharmaceuticals market share: % share, by value, 2015
Table 8: Brazil OTC pharmaceuticals market distribution: % share, by value, 2015
Table 9: Brazil OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 10: Brazil size of population (million), 2011-15
Table 11: Brazil gdp (constant 2005 prices, $ billion), 2011-15
Table 12: Brazil gdp (current prices, $ billion), 2011-15
Table 13: Brazil inflation, 2011-15
Table 14: Brazil consumer price index (absolute), 2011-15
Table 15: Brazil exchange rate, 2011-15
Table 16: China OTC pharmaceuticals market value: $ million, 2011-15
Table 17: China OTC pharmaceuticals market category segmentation: $ million, 2015
Table 18: China OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 19: China OTC pharmaceuticals market share: % share, by value, 2015
Table 20: China OTC pharmaceuticals market distribution: % share, by value, 2015
Table 21: China OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 22: China size of population (million), 2011-15
Table 23: China gdp (constant 2005 prices, $ billion), 2011-15
Table 24: China gdp (current prices, $ billion), 2011-15
Table 25: China inflation, 2011-15
Table 26: China consumer price index (absolute), 2011-15
Table 27: China exchange rate, 2011-15
Table 28: India OTC pharmaceuticals market value: $ million, 2011-15
Table 29: India OTC pharmaceuticals market category segmentation: $ million, 2015
Table 30: India OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 31: India OTC pharmaceuticals market share: % share, by value, 2015
Table 32: India OTC pharmaceuticals market distribution: % share, by value, 2015
Table 33: India OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 34: India size of population (million), 2011-15
Table 35: India gdp (constant 2005 prices, $ billion), 2011-15
Table 36: India gdp (current prices, $ billion), 2011-15
Table 37: India inflation, 2011-15
Table 38: India consumer price index (absolute), 2011-15
Table 39: India exchange rate, 2011-15
Table 40: Russia OTC pharmaceuticals market value: $ million, 2011-15
Table 41: Russia OTC pharmaceuticals market category segmentation: $ million, 2015
Table 42: Russia OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 43: Russia OTC pharmaceuticals market share: % share, by value, 2015
Table 44: Russia OTC pharmaceuticals market distribution: % share, by value, 2015
Table 45: Russia OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 46: Russia size of population (million), 2011-15
Table 47: Russia gdp (constant 2005 prices, $ billion), 2011-15
Table 48: Russia gdp (current prices, $ billion), 2011-15
Table 49: Russia inflation, 2011-15
Table 50: Russia consumer price index (absolute), 2011-15
Table 51: Russia exchange rate, 2011-15
Table 52: Abbott Laboratories: key facts
Table 53: Abbott Laboratories: key financials ($)
Table 54: Abbott Laboratories: key financial ratios
Table 55: GlaxoSmithKline Plc: key facts
Table 56: GlaxoSmithKline Plc: key financials ($)
Table 57: GlaxoSmithKline Plc: key financials (£)
Table 58: GlaxoSmithKline Plc: key financial ratios
Table 59: Johnson and Johnson: key facts
Table 60: Johnson and Johnson: key financials ($)
Table 61: Johnson and Johnson: key financial ratios
Table 62: Sanofi SA: key facts
Table 63: Sanofi SA: key financials ($)
Table 64: Sanofi SA: key financials (€)
Table 65: Sanofi SA: key financial ratios
Table 66: Huangshan Tianmu Pharmaceutical Co., Ltd.: key facts
Table 67: Nin Jiom Medicines Manufactory Ltd: key facts
Table 68: Cipla Limited: key facts
Table 69: Cipla Limited: key financials ($)
Table 70: Cipla Limited: key financials (Rs.)
Table 71: Cipla Limited: key financial ratios
Table 72: Dabur India Limited: key facts
Table 73: Dabur India Limited: key financials ($)
Table 74: Dabur India Limited: key financials (Rs.)
Table 75: Dabur India Limited: key financial ratios
Table 76: JSC ELFA: key facts
Table 77: The Menarini Group: key facts
Table 78: The Menarini Group: key financials ($)
Table 79: The Menarini Group: key financials (€)
Table 80: The Menarini Group: key financial ratios
Table 81: Pharmstandard OJSC: key facts
Table 82: Pharmstandard OJSC: key financials ($)
Table 83: Pharmstandard OJSC: key financials (RUB)
Table 84: Pharmstandard OJSC: key financial ratios

LIST OF FIGURES

Figure 1: BRIC otc pharmaceuticals industry, revenue($m), 2011-20
Figure 2: BRIC otc pharmaceuticals industry, revenue($m), 2011-15
Figure 3: BRIC otc pharmaceuticals industry, revenue($m), 2015-20
Figure 4: Brazil OTC pharmaceuticals market value: $ million, 2011-15
Figure 5: Brazil OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 6: Brazil OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 7: Brazil OTC pharmaceuticals market share: % share, by value, 2015
Figure 8: Brazil OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 9: Brazil OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 10: Forces driving competition in the OTC pharmaceuticals market in Brazil, 2015
Figure 11: Drivers of buyer power in the OTC pharmaceuticals market in Brazil, 2015
Figure 12: Drivers of supplier power in the OTC pharmaceuticals market in Brazil, 2015
Figure 13: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Brazil, 2015
Figure 14: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Brazil, 2015
Figure 15: Drivers of degree of rivalry in the OTC pharmaceuticals market in Brazil, 2015
Figure 16: China OTC pharmaceuticals market value: $ million, 2011-15
Figure 17: China OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 18: China OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 19: China OTC pharmaceuticals market share: % share, by value, 2015
Figure 20: China OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 21: China OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 22: Forces driving competition in the OTC pharmaceuticals market in China, 2015
Figure 23: Drivers of buyer power in the OTC pharmaceuticals market in China, 2015
Figure 24: Drivers of supplier power in the OTC pharmaceuticals market in China, 2015
Figure 25: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in China, 2015
Figure 26: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in China, 2015
Figure 27: Drivers of degree of rivalry in the OTC pharmaceuticals market in China, 2015
Figure 28: India OTC pharmaceuticals market value: $ million, 2011-15
Figure 29: India OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 30: India OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 31: India OTC pharmaceuticals market share: % share, by value, 2015
Figure 32: India OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 33: India OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 34: Forces driving competition in the OTC pharmaceuticals market in India, 2015
Figure 35: Drivers of buyer power in the OTC pharmaceuticals market in India, 2015
Figure 36: Drivers of supplier power in the OTC pharmaceuticals market in India, 2015
Figure 37: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in India, 2015
Figure 38: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in India, 2015
Figure 39: Drivers of degree of rivalry in the OTC pharmaceuticals market in India, 2015
Figure 40: Russia OTC pharmaceuticals market value: $ million, 2011-15
Figure 41: Russia OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 42: Russia OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 43: Russia OTC pharmaceuticals market share: % share, by value, 2015
Figure 44: Russia OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 45: Russia OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 46: Forces driving competition in the OTC pharmaceuticals market in Russia, 2015
Figure 47: Drivers of buyer power in the OTC pharmaceuticals market in Russia, 2015
Figure 48: Drivers of supplier power in the OTC pharmaceuticals market in Russia, 2015
Figure 49: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Russia, 2015
Figure 50: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Russia, 2015
Figure 51: Drivers of degree of rivalry in the OTC pharmaceuticals market in Russia, 2015
Figure 52: Abbott Laboratories: revenues and profitability
Figure 53: Abbott Laboratories: assets and liabilities
Figure 54: GlaxoSmithKline Plc: revenues and profitability
Figure 55: GlaxoSmithKline Plc: assets and liabilities
Figure 56: Johnson and Johnson: revenues and profitability
Figure 57: Johnson and Johnson: assets and liabilities
Figure 58: Sanofi SA: revenues and profitability
Figure 59: Sanofi SA: assets and liabilities
Figure 60: Cipla Limited: revenues and profitability
Figure 61: Cipla Limited: assets and liabilities
Figure 62: Dabur India Limited: revenues and profitability
Figure 63: Dabur India Limited: assets and liabilities
Figure 64: Pharmstandard OJSC: revenues and profitability
Figure 65: Pharmstandard OJSC: assets and liabilities
Skip to top


Ask Your Question

OTC Pharmaceuticals BRIC (Brazil, Russia, India, China) Industry Guide_2016
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: